This summary was created by AI, based on 1 opinions in the last 12 months.
Cellebrite (CLBT-Q) is highly regarded for its ability to trace data for law enforcement and military agencies. The application of AI in data analysis provides a valuable tool for sifting through large volumes of information, enabling swift identification of clues and patterns. Its substantial cash reserves and strong growth potential, coupled with a relatively small market cap, underscore its promise among competitors in the sector. These strengths have instilled confidence in its customer base.
Cellebrite is a American stock, trading under the symbol CLBT-Q on the NASDAQ (CLBT). It is usually referred to as NASDAQ:CLBT or CLBT-Q
In the last year, there was no coverage of Cellebrite published on Stockchase.
Cellebrite was recommended as a Top Pick by on . Read the latest stock experts ratings for Cellebrite.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Cellebrite published on Stockchase.
On 2024-12-13, Cellebrite (CLBT-Q) stock closed at a price of $19.88.
It is very good at tracing data for the police, military and other agencies. One of the best use cases for AI is looking at data. This is so good for the overwhelming amount of info that police have to look at. CLBT scrubs the info to find clues and patterns and can find information quickly. It has $400 million in cash along with very good growth. With a market cap of less than $4 billion it is much smaller than other companies in the same field. The customer base gives confidence in the company. Buy 8 Hold 0 Sell 0
(Analysts’ price target is $22.43)